Mark Augustine
Mark Augustine
appreciate associated believe fully lead risks street
We believe that the Street does not fully appreciate the risks associated with the company's two lead programs.
again asking investors past price shares stick stock target
Vertex shares are once again challenging our price target and with the stock up 250% over the past year, investors may be asking what to do with the stock. We would stick with Vertex.
derby early encounter exit looking obstacles price prior shares stumble wind
Vertex shares may not be for the faint-hearted at these price levels. However, the hepatitis C derby is just that: a race. Should Vertex not stumble or encounter unforeseen obstacles prior to approval, $35 will wind up looking like an early exit point.